GH(Guardant Health, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $373.65M | $449.54M | $563.95M | $739.02M | $982.02M |
| 毛利润 | — | — | $336.90M | $449.22M | $633.01M |
| 营业利润 | −$411.00M | −$544.38M | −$564.73M | −$443.59M | −$437.25M |
| 净利润 | −$384.77M | −$654.59M | −$479.45M | −$436.37M | −$416.28M |
| 经营现金流 | −$209.02M | −$309.46M | −$324.98M | −$239.86M | −$184.76M |
| 自由现金流 | −$284.05M | −$386.92M | −$345.46M | −$274.94M | −$233.07M |
| 摊薄每股收益 | $-4.00 | $-6.41 | $-4.28 | $-3.56 | $-3.32 |